Skip to main content

Advertisement

SpringerLink
Log in

Quality of Life in Cirrhosis

  • Liver (B Bacon, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Quality of life is a construct that reflects the positive and negative aspects of one’s life, and is expanded upon by health-related quality of life (HRQL), which specifically address the impact of health on patients’ well-being. Cirrhosis is the culmination of various pathways that leads into development of advanced hepatic fibrosis with its complications. This paper addresses the impact of cirrhosis on individuals HRQL. In addition, we will define what disease specific and general HRQL instruments aim to measure. We discuss the liver disease specific scales [Chronic Liver Disease Questionnaire (CLDQ), Liver Disease Quality of Life 1.0 (LDQOL)] and the most commonly used generic health profile [Short Form 36 Profile (SF-36)]. Furthermore, we examine recent literature which describes how to measure and what is known about quality of life of patients with cirrhosis. This information gives insight to health care providers concerning the impact of disease on patients if treatments are not only to improve health but also function and unexpected treatment outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Davis GL, Later MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138:513–21.

    Article  PubMed  Google Scholar 

  2. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–21.

    Article  PubMed  Google Scholar 

  3. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;9(4):331–8.

    Article  PubMed  Google Scholar 

  4. • McGarry LJ, Pawar VS, Parekh HH, et al. Economic model of a birth cohort screening program for hepatitis C virus. Hepatology. 2012;55:1344–55. Important paper about screening for HCV.

  5. • Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med. 2012;156(4):263–70. Epub 2011 Nov 4. Important paper about screening for HCV.

  6. Anonymous. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1–32.

  7. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491–7. Epub 2012 Jan 17.

    Article  PubMed  Google Scholar 

  8. • Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9(6):524–30. Important paper about prevalence of CLD in the USA

  9. Rakoski MO, McCammon RJ, Piette JD, Iwashyna TJ, Marrero JA, Lok AS, Langa KM, Volk ML. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012;55(1):184–91. doi:10.1002/hep.24616.

    Article  PubMed  Google Scholar 

  10. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 1978;31(5):395–414.

    Article  PubMed  CAS  Google Scholar 

  11. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med. 2005;60(4):833–43. Review.

    Article  PubMed  Google Scholar 

  12. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R. Factors associated with poor health-related quality of life patients with cirrhosis. Gastroenterol. 2001;120:170–8.

    Article  CAS  Google Scholar 

  13. Owen JE, Boxley L, Klapow JC. Measurement of quality of life outcomes. In: Berger AM, Shuster JL, Von Roenn JH, editors. Principles & Practice of Palliative Care & Supportive Oncology. Philadelphia: Lippincott-Raven Publishers; 1998. p. 878–9.

    Google Scholar 

  14. Dan AA, Younossi ZM. Long-term improvement in health-related quality of life after orthotopic liver transplantation. Liver Transpl. 2008;14(10):1404–5.

    Article  PubMed  Google Scholar 

  15. • Starr SP, Raines D. Cirrhosis: diagnosis, management, and prevention. Am Fam Physician. 2011;84(12):1353–9. Review. This article gives great insight into the complications of cirrhosis and how diagnosis and prevention can reduce incidences of cirrhosis.

    PubMed  Google Scholar 

  16. Kochanek KD, Xu J, Murphy SL, Minino AM, Ching Kung H. Deaths: final data for 2009. In: National Vital Statistics Reports. 2011. http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_03.pdf. Accessed 19 April 2012.

  17. Dan AA, Martin LM, Crone C, Ong JP, Farmer DW, Wise T, Robbins SC, Younossi ZM. Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol. 2006; 44(3):491–8.

    Google Scholar 

  18. Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology. 2007;45:806–16.

    Article  PubMed  CAS  Google Scholar 

  19. Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011. doi:10.1038/ajg.2011.157.

  20. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician. 2006;74(5):756–62. Review.

    PubMed  Google Scholar 

  21. Grattagliano I, Ubaldi E, Bonfrate L, Portincasa P. Management of liver cirrhosis between primary care and specialists. World J Gastroenterol. 2011;17(18):2273–82.

    Article  PubMed  Google Scholar 

  22. Alizadeh AH, Ranjbar M, Yadollahzadeh M. Patient concerns regarding chronic hepatitis B and C infection. East Mediterr Health J. 2008;14(5):1142–7.

    PubMed  CAS  Google Scholar 

  23. Minuk GY, Gutkin A, Wong SG, Kaita KD. Patient concerns regarding chronic hepatitis C infections. J Viral Hepat. 2005;12(1):51–7.

    Article  PubMed  CAS  Google Scholar 

  24. Otgonsuren M, Venkatesan C, Mishra A, Erari M, Younossi ZM. Mortality and Resource Utilization Associated with the Inpatient Diagnosis of Liver Disease in the United States. Hepatology. 2012 (Abstract).56 (N0.4, Supplement):1096A.

  25. Neff GW, Duncan CW, Schiff ER. The current economic burden of cirrhosis. Gastroenterol Hepatol. 2011;7(10):661–71.

    Google Scholar 

  26. Miniño AM, Xu J, Kochanek KD, Tejada-Vera B. Death in the United States, 2007. NCHS Data Brief. 2009;26:1–8.

    PubMed  Google Scholar 

  27. Kogure T, Ueno Y, Kawagishi N, Kanno N, Yamagiwa Y, Fukushima K, Satomi S, Shimosegawa T. The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol. 2006;41(10):1005–10. Epub 2006 Nov 9.

    Article  PubMed  Google Scholar 

  28. Aberg F, Höckerstedt K, Roine RP, Sintonen H, Isoniemi H. Influence of liver-disease etiology on long-term quality of life and employment after liver transplantation. Clin Transplant. 2012. doi:10.1111/j.1399-0012.2012.01597.x [Epub ahead of print].

  29. Fryback GD. Measuring health-related quality of life. Workshop on advancing social science theory: the importance of common metricks. Washington, D.C.: The National Academies, Division of Behavioral and Social Sciences and Education; 2010.

    Google Scholar 

  30. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295–300.

    Article  PubMed  CAS  Google Scholar 

  31. Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, Kim S, Lazarovici D, Jensen DM, Busuttil RW, Martin P. Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease-the LDQOL 1.0. Am J Gastroenterol. 2000;95(12):3552–65.

    PubMed  CAS  Google Scholar 

  32. Kallman J, O'Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci. 2007;52(10):2531–9. Epub 2007 Apr 4.

    Article  PubMed  Google Scholar 

  33. • Dan AA, Kallman JB, Wheeler A, Younoszai Z, Collantes R, Bondini S, Gerber L, Younossi ZM. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;26(6):815–20. This article discusses how severely impaired HRQL was in a population of patients with chronic liver disease (NAFLD).

    Article  PubMed  CAS  Google Scholar 

  34. Kollia Z, Patelarou E, Vivilaki V, Kollia E, Kefou F, Elefsiniotis I, Dourakis SP, Brokalaki H. Translation and validation of the Greek chronic liver disease questionnaire. World J Gastroenterol. 2010;16(46):5838–44.

    Article  PubMed  Google Scholar 

  35. Ray I, Dutta D, Basu P, De BK. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire. Indian J Gastroenterol. 2010;29(5):187–95. Epub 2010 Aug 26.

    Article  PubMed  Google Scholar 

  36. Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY. Psychometrics of the chronic liver disease questionnaire for Southern Chinese patients with chronic hepatitis B virus infection. World J Gastroenterol. 2009;15(26):3288–97.

    Article  PubMed  Google Scholar 

  37. Ferrer M, Córdoba J, Garin O, Olivé G, Flavià M, Vargas V, Esteban R, Alonso J. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006;12(1):95–104.

    Article  PubMed  Google Scholar 

  38. Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol. 2004;10(13):1954–7.

    PubMed  Google Scholar 

  39. Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol. 2001;96(2):579–83.

    Article  PubMed  CAS  Google Scholar 

  40. Kim JH, Kwon SY, Lee YS, Lee JH, Lee YS, Lee CH. Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2012;10(3):291–6. Epub 2011 Oct 20.

    Article  PubMed  Google Scholar 

  41. Jafferbhoy H, Gashau W, Dillon J. Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection. Clinicoecon Outcomes Res. 2010;2:87–96. Epub 2010 Jul 14.

    PubMed  CAS  Google Scholar 

  42. Mahmoudi H, Jafari P, Alizadeh-Naini M, Gholami S, Malek-Hosseini SA, Ghaffaripour S. Validity and reliability of Persian version of chronic liver disease questionnaire (CLDQ). Qual Life Res. 2011 Nov 13. [Epub ahead of print].

  43. Saab S, Ibrahim A, Shpaner A, Younossi ZM, Lee C, Durazo F, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl. 2005;11:218–23.

    Article  PubMed  Google Scholar 

  44. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96(7):2199–205.

    Article  PubMed  CAS  Google Scholar 

  45. • Sanyal A, Younossi ZM_, Bass N, Mullen KD, Poordad F, Brown R, et al. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic nencephalopathy – a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2011;34:853–61. A large RCT describing HRQL in patients with HE using both CLDQ and SF-36.

  46. Ong JP, Oehler G, Krüger-Jansen C, Lambert-Baumann J, Younossi ZM. Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. Clin Drug Investig. 2011;31(4):213–20.

    Article  PubMed  CAS  Google Scholar 

  47. Younossi ZM, Boparai N, McCormick M. A disease-specific health-related quality of life instrument for chronic hepatitis C: CLDQ-HCV. Hepatology. 2000. (Abstract).

  48. Dan AA, Crone C, Wise TN, Martin LM, Ramsey L, Magee S, Sjogren R, Ong JP, Younossi ZM. Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life. Psychosomatics. 2007;48(3):223–9.

    Article  PubMed  Google Scholar 

  49. Loria A, Escheik CE, Gerber NL, Price JK, Younossi ZM. The Chronic Liver Disease Questionnaire-Hepatitis C (CLDQ-HCV): a sensitive and valid health related quality of life instrument. Hepatology. 2012. (Abstract).

  50. Two R, Verjee-Lorenz A, Clayson D, Dalal M, Grotzinger K, Younossi ZM. Response to the letter from Ms. Tamzin Furtado. Value Health. 2010;13(4):508–14.

    Article  Google Scholar 

  51. Gotardo DR, Strauss E, Teixeira MC, Machado MC. Liver transplantation and quality of life: relevance of a specific liver disease questionnaire. Liver Int. 2008;28(1):99–106. Epub 2007 Nov 1.

    Article  PubMed  Google Scholar 

  52. Ortega T, Deulofeu R, Salamero P, Casanovas T, Rimola A, Pont T, Caldes A, Twose J, Ortega F, Red Tematica de Investigacion en Trasplante. Impact of health related quality of life in catalonia liver transplant patients. Transplant Proc. 2009;41(6):2187–8.

    Article  PubMed  CAS  Google Scholar 

  53. Casanovas Taltavull T, Jané Cabré L, Herdman M, Casado Collado A, Pubill BP, Fabregat Prous J. Validation of the Spanish version of the liver disease quality of life instrument among candidates for liver transplant. Transplant Proc. 2007;39(7):2274–7.

    Article  PubMed  CAS  Google Scholar 

  54. Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol. 2004;99(9):1726–32.

    Article  PubMed  Google Scholar 

  55. WHO. Constitution of the world health organization. The constitution was adopted by the International Health Conference, New York, 19 June - 22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100). http://www.who.int/governance/eb/who_constitution_en.pdf. Accessed 19 April 2012.

  56. Escheik CE, Gerber NL, Rover L, Arsalla Z, Otgonsuren M, Younossi ZM. Validation of CLDQ-HCV as a health related quality of life (HRQL) instrument for patients with chronic hepatitis C (CH-C). ACG 2012 (Abstract).107 (Supplement):1252

  57. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36).I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.

    Article  PubMed  Google Scholar 

  58. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther. 2009;30(5):469–76. Epub 2009 Jun 9.

    Article  PubMed  CAS  Google Scholar 

  59. Solà E, Watson H, Graupera I, Turón F, Barreto R, Rodríguez E, Pavesi M, Arroyo V, Guevara M, Ginès P. Factors related to quality of life in patients with cirrhosis and ascites. Relevance of serum sodium concentration and leg edema. J Hepatol. 2012;57(6):1199–206

    Google Scholar 

  60. Moscucci F, Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Merli M, Riggio O. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int. 2011;31(10):1505–10. doi:10.1111/j.1478-3231.2011.02598.x. Epub 2011 Aug 15.

    Article  PubMed  Google Scholar 

  61. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–8.

    Article  PubMed  CAS  Google Scholar 

  62. Younossi ZM. Chronic liver disease and health-related quality of life. Gastroenterology. 2001;120(1):305–7.

    Article  PubMed  CAS  Google Scholar 

  63. Kallman-Price J, Younossi Z. Quality of life in hepatic encephalopathy. In: Mullen KD and Prakash RK, editors. Hepatic encephalopathy, clinical gastroenterology. doi 10.1007/978-1-61779-836-8_18, © Springer Science; 2012.

  64. Saab S, Ng V, Landaverde C, Lee S, Comulada WS, Arevalo J, Durazo F, Han S, Younossi ZM, Busuttil RW. Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transpl. 2011;17:567–79.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA

    Anthony Loria & Zobair M. Younossi

  2. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA

    Anthony Loria, Carey Escheik, N. Lynn Gerber & Zobair M. Younossi

  3. Betty and Guy Beatty Center for Integrated Research, Claude Moore Health Education and Research Building, 3300 Gallows Road, Falls Church, VA, 22042, USA

    Zobair M. Younossi

Authors
  1. Anthony Loria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carey Escheik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Lynn Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zobair M. Younossi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zobair M. Younossi.

Additional information

This article is part of the Topical Collection on Liver

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loria, A., Escheik, C., Gerber, N.L. et al. Quality of Life in Cirrhosis. Curr Gastroenterol Rep 15, 301 (2013). https://doi.org/10.1007/s11894-012-0301-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11894-012-0301-5

Keywords

Search

Navigation